INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
04/01/2026
Back to search
Official data from USPTO
TEMIXYS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
37
Latest update
04/02/2026
Trademark type
Word
Nice classes
5
Filing date
02/01/2018
Registration date
01/15/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/01/2025
Last transaction
04/02/2026
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
KR
Examiner
OSGOOD, KRYSTINA E
Law office
N30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
CELLTRION, INC.
Representatives
Kisuk Lee Harness, Dickey & Pierce, PLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of neurogenic detrusor overactivity; drugs being pharmaceutical preparations for the treatment of iron overloadmigraine and diabetes; medicines for the treatment of cardiacneurologicmetabolicgeneticpsychologic and psychiatric diseases and disorders; ethical medicinal preparations for prevention and treatment of low blood pressure; biological preparations for medical purposes for the treatment of infectious diseasestumor-related diseasesauto-immune diseaseshormone-deficiency diseases; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical products for the treatment of viral diseases; vaccines; pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for the prevention of autoimmune diseases; anti-infectives; antivirals; antibiotics; antiepileptic drugsanti-epileptic pharmaceutical preparations; dietary supplements; vitamin and mineral preparations for medical use; pharmaceuticalspharmaceutical preparations for the prevention of HIV/AIDS infection; pharmaceuticalspharmaceutical preparations for the treatment of HIV/AIDS
Publications
History of USPTO decisions and trademark events.
37 publications found
C71T
CANCELLED SECTION 71
08/01/2025
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
01/15/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/05/2021
NREP
NEW REPRESENTATIVE AT IB RECEIVED
02/12/2021
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/25/2019
FICS
FINAL DISPOSITION NOTICE SENT TO IB
05/04/2019
FIMP
FINAL DISPOSITION PROCESSED
05/04/2019
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04/15/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
01/15/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/30/2018
PUBO
PUBLISHED FOR OPPOSITION
10/30/2018
GPNX
NOTIFICATION PROCESSED BY IB
10/26/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
10/10/2018
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
10/10/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/10/2018
ALIE
ASSIGNED TO LIE
09/17/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/05/2018
XAEC
EXAMINER'S AMENDMENT ENTERED
08/30/2018
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
08/30/2018
GNEA
EXAMINERS AMENDMENT E-MAILED
08/30/2018
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/30/2018
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/22/2018
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/22/2018
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/22/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/22/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/22/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/22/2018
RFNT
REFUSAL PROCESSED BY IB
06/08/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
05/21/2018
RFRR
REFUSAL PROCESSED BY MPU
05/21/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
05/16/2018
CNRT
NON-FINAL ACTION WRITTEN
05/15/2018
DOCK
ASSIGNED TO EXAMINER
05/15/2018
MAFR
APPLICATION FILING RECEIPT MAILED
04/10/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/06/2018
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
04/05/2018
Continuous trademark protection
Get notified about every new filing that threatens TEMIXYS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.